[go: up one dir, main page]

AU5274000A - Prevention of regression in refractive keratoplasty - Google Patents

Prevention of regression in refractive keratoplasty

Info

Publication number
AU5274000A
AU5274000A AU52740/00A AU5274000A AU5274000A AU 5274000 A AU5274000 A AU 5274000A AU 52740/00 A AU52740/00 A AU 52740/00A AU 5274000 A AU5274000 A AU 5274000A AU 5274000 A AU5274000 A AU 5274000A
Authority
AU
Australia
Prior art keywords
regression
prevention
refractive keratoplasty
keratoplasty
refractive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52740/00A
Inventor
Bruce J. Sand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUNRISE TECHNOLOGIES INTERNATIONAL Inc
Original Assignee
SUNRISE TECHNOLOGIES INTERNATI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUNRISE TECHNOLOGIES INTERNATI filed Critical SUNRISE TECHNOLOGIES INTERNATI
Publication of AU5274000A publication Critical patent/AU5274000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU52740/00A 1999-06-04 2000-05-15 Prevention of regression in refractive keratoplasty Abandoned AU5274000A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US13745999P 1999-06-04 1999-06-04
US60137459 1999-06-04
US14506999P 1999-07-20 1999-07-20
US60145069 1999-07-20
US14712399P 1999-08-04 1999-08-04
US60147123 1999-08-04
US15277399P 1999-09-03 1999-09-03
US60152773 1999-09-03
US15358999P 1999-09-13 1999-09-13
US60153589 1999-09-13
US16114799P 1999-10-22 1999-10-22
US60161147 1999-10-22
US55057900A 2000-04-17 2000-04-17
US09550579 2000-04-17
PCT/US2000/013600 WO2000074648A2 (en) 1999-06-04 2000-05-15 Prevention of regression in refractive keratoplasty

Publications (1)

Publication Number Publication Date
AU5274000A true AU5274000A (en) 2000-12-28

Family

ID=27568914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52740/00A Abandoned AU5274000A (en) 1999-06-04 2000-05-15 Prevention of regression in refractive keratoplasty

Country Status (2)

Country Link
AU (1) AU5274000A (en)
WO (1) WO2000074648A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
US8992516B2 (en) 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
US8202272B2 (en) 2007-07-19 2012-06-19 Avedro, Inc. Eye therapy system
WO2009073213A1 (en) * 2007-12-05 2009-06-11 Avedro, Inc. Eye therapy system
US8409189B2 (en) 2008-01-23 2013-04-02 Avedro, Inc. System and method for reshaping an eye feature
US8348935B2 (en) 2008-01-23 2013-01-08 Avedro, Inc. System and method for reshaping an eye feature
US8469952B2 (en) 2008-01-23 2013-06-25 Avedro, Inc. System and method for positioning an eye therapy device
JP2012502763A (en) 2008-09-19 2012-02-02 アヴェドロ・インコーポレーテッド Eye therapy system
US8366689B2 (en) 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
US8460278B2 (en) 2008-10-01 2013-06-11 Avedro, Inc. Eye therapy system
WO2010056848A1 (en) 2008-11-11 2010-05-20 Avedro, Inc. Eye therapy system
US8712536B2 (en) 2009-04-02 2014-04-29 Avedro, Inc. Eye therapy system
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
WO2011053768A2 (en) 2009-10-30 2011-05-05 Avedro, Inc. System and method for stabilizing corneal tissue after treatment
EP4480461A3 (en) 2010-03-19 2025-02-12 Avedro, Inc. Systems for applying and monitoring eye therapy
US20120289886A1 (en) * 2010-04-13 2012-11-15 Avedro, Inc. Controlled application of cross-linking agent
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
WO2013059837A2 (en) 2012-07-16 2013-04-25 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
EP3212140B1 (en) 2014-10-27 2021-12-01 Avedro, Inc. Systems for cross-linking treatments of an eye
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3285704B1 (en) 2015-04-24 2020-11-18 Avedro Inc. Systems for photoactivating a photosensitizer applied to an eye
EP4483884A3 (en) 2015-05-22 2025-03-05 Avedro Inc. Systems for monitoring cross-linking activity for corneal treatments
JP6933377B2 (en) 2015-07-21 2021-09-08 アヴェドロ・インコーポレーテッドAvedro,Inc. Eye treatment systems and methods using photosensitizers
BR112018007437A2 (en) 2015-10-23 2018-10-23 Univ Columbia laser-induced collagen cross-linking in tissue
WO2017214604A1 (en) 2016-06-10 2017-12-14 The Trustees Of Columbia University In The City Of New York Devices, methods, and systems for detection of collagen tissue features
US11666481B1 (en) 2017-12-01 2023-06-06 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of collagen-containing tissues
EP4260834B1 (en) 2018-03-05 2025-05-07 Avedro, Inc. System for eye tracking during eye treatment
US11766356B2 (en) 2018-03-08 2023-09-26 Avedro, Inc. Micro-devices for treatment of an eye
CA3112937A1 (en) 2018-09-19 2020-03-26 Avedro, Inc. Systems and methods treating for corneal ectatic disorders
CN119769986A (en) 2018-09-19 2025-04-08 艾维德洛公司 Systems and methods for eye tracking during eye treatment
JP7596262B2 (en) 2018-10-09 2024-12-09 アヴェドロ・インコーポレーテッド Photoactivation system and method for corneal crosslinking treatment
JP7571038B2 (en) 2019-02-26 2024-10-22 アヴェドロ・インコーポレーテッド Systems and methods for ophthalmic cross-linking procedures
US11642244B2 (en) 2019-08-06 2023-05-09 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US12293513B2 (en) 2021-03-08 2025-05-06 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114627A (en) 1986-10-16 1992-05-19 Cbs Lens Method for producing a collagen hydrogel
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5270051A (en) 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US6013628A (en) 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides
BR9610070A (en) 1995-08-08 1999-07-27 Univ Jefferson Antifibrotic compound polypeptide nucleic acid sequence and process for treating fibrosis-related disorders or diseases to use the DNA sequence and to produce recombinant c-proteinase
US6033396A (en) 1995-11-06 2000-03-07 Huang; David Apparatus and method for performing laser thermal keratoplasty with minimized regression
KR20000016143A (en) 1996-05-30 2000-03-25 리차드 에이취 리저 Mammalian tolloid-like gene and protein
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6037139A (en) 1997-06-03 2000-03-14 Wisconsin Alumni Research Foundation System for assaying modulators of procollagen maturation

Also Published As

Publication number Publication date
WO2000074648A3 (en) 2001-02-01
WO2000074648A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AU5274000A (en) Prevention of regression in refractive keratoplasty
AU1731101A (en) Ophthalmic compositions
AU3728800A (en) Multi-purpose eyewear
AU3731600A (en) Composition and structures made therefrom
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU6820000A (en) Novel proteases and variants thereof
AU5727200A (en) Super vision
AUPQ419099A0 (en) Novel compositions and methods
AU7533500A (en) Tessellation set
AU4819300A (en) Methods of refractive correction of the eye
AU1932801A (en) Foldable eyewear
AU2447101A (en) Judging changes in images of the eye
AU5634300A (en) Composition and films thereof
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU1403501A (en) Novel composition and use
AU5495101A (en) Ophthalmic injector
AU3175900A (en) Tampon
AU4354600A (en) Cleaning compositions and tablets
AU2841801A (en) Triazolotriazinones and the use thereof
AU1152601A (en) Compositions and their use
AU4309700A (en) Spectacles
AU1554301A (en) Radioprotecting agent
AU3328600A (en) Ocular tension-lowering agents
AU2001264522A1 (en) Methods and compositions for the prevention of myopia

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase